Skip to main content

Peer Review reports

From: Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report

Original Submission
21 May 2022 Submitted Original manuscript
8 Apr 2023 Reviewed Reviewer Report - Hideki Ota
10 Apr 2023 Reviewed Reviewer Report
20 Aug 2023 Author responded Author comments - Ruixin Xu
Resubmission - Version 2
20 Aug 2023 Submitted Manuscript version 2
Publishing
3 Nov 2023 Editorially accepted
10 Nov 2023 Article published 10.1186/s13019-023-02427-7

You can find further information about peer review here.

Back to article page